| Authors: |
Morita J; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Hida N; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Setagaya-ku, Tokyo, Japan.; SHOWA Medical University Clinical Research Institute for Clinical Pharmacology and Therapeutics, Setagaya-ku, Tokyo, Japan., Yonemura T; Souseikai Sumida Hospital, Tokyo, Japan., Yamazaki T; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Setagaya-ku, Tokyo, Japan.; SHOWA Medical University Clinical Research Institute for Clinical Pharmacology and Therapeutics, Setagaya-ku, Tokyo, Japan., Sato H; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Sumiya M; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Takaya R; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Kumagai Y; Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan., Uchida N; Department of Clinical Pharmacology, Graduate School of Medicine, SHOWA Medical University, Setagaya-ku, Tokyo, Japan. |